Home/Filings/4/0001104659-25-082633
4//SEC Filing

Taylor Andrew Lawrence 4

Accession 0001104659-25-082633

CIK 0001814114other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 7:01 PM ET

Size

4.8 KB

Accession

0001104659-25-082633

Insider Transaction Report

Form 4
Period: 2025-08-25
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2025-08-25$2.55/sh+2,000$5,100482,788 total

Issuer

Orchestra BioMed Holdings, Inc.

CIK 0001814114

Entity typeother

Related Parties

1
  • filerCIK 0001723889

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:01 PM ET
Size
4.8 KB